chronic myelocytic leukemia

(redirected from Chronic myelogenous leukemia)
Also found in: Thesaurus, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.chronic myelocytic leukemia - chronic leukemia characterized by granular leukocytes; more common in older people
chronic leukemia - slowly progressing leukemia
granulocytic leukemia, myelocytic leukemia - a malignant neoplasm of blood-forming tissues; marked by proliferation of myelocytes and their presence in the blood
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
[ClickPress, Tue Jun 18 2019] Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells.
Acute tumour lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
The Type II Variation application for Bosulif for adults with newly diagnosed chronic phase Ph+ CML was based on results from BFORE (Bosutinib trial in First line chrOnic myelogenous leukemia tREatment), a randomized multicenter, multinational, open-label, Phase 3, head-to-head study of Bosulif 400 mg versus imatinib 400 mg, a current standard of care.
Chronic Myelogenous Leukemia (CML) is a myeloproliferative hematopoietic neoplasm, characterized by a balanced translocation of Abelson gene on chromosome 9q34 with breakpoint cluster region gene on chromosome 22q11.2 (BCR-ABL1) [1].
Chronic myelogenous leukemia (CML) is the most common of the MPDs and can occur at any age.
[2] Unusual presentation of chronic myelogenous leukemia. A review of isolated central nervous system relapse.
Chronic myelogenous leukemia (CML), orchronic granulocytic leukemia (CGL), is the white blood cells cancer.
Philadelphia chromosome is found in most patients with chronic myelogenous leukemia (CML) and sometimes also in acute lymphoblastic leukemia and acute myelogenous leukemia.
Chronic myelogenous leukemia (CML) is classified as a myeloproliferative neoplasm which usually progresses from a relatively indolent disease to a more aggressive disorder, during which time disease control is harder to achieve [1].
Huber, "Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: a 5-year follow up," American Journal of Hematology, vol.
Prior to that, he was responsible for teams at BMS that advanced more than 20 compounds into clinical development including SPRYCEL (dasatinib) for the treatment of chronic myelogenous leukemia, which he co-invented.

Full browser ?